Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Maria Silvia Cona"'
Autor:
Lorenzo Ruggieri, Anna Lisa Ridolfo, Sara Giordana Rimoldi, Maria Silvia Cona, Davide Dalu, Pietro Olivieri, Giuliano Rizzardini, Spinello Antinori, Anna Gambaro, Sabrina Ferrario, Cinzia Fasola, Maria Antista, Carmen Giusy Rea, Nicla La Verde
Publikováno v:
Hygiene, Vol 4, Iss 2, Pp 157-163 (2024)
Ralstonia spp. are low-virulent environmental Gram-negative bacteria that can cause serious nosocomial infections in immunocompromised patients. We report the characteristics of a cluster of R. insidiosa bacteremia cases occurring in our oncology day
Externí odkaz:
https://doaj.org/article/3e64267aa7e94b44a054c149382d5eff
Autor:
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, Maria Silvia Cona, Agostino Riva, Davide De Francesco, Chiara Tricella, Cinzia Fasola, Sabrina Ferrario, Anna Gambaro, Benedetta Lombardi Stocchetti, Valeria Smiroldo, Gaia Rebecchi, Sheila Piva, Giorgia Carrozzo, Spinello Antinori, Nicla La Verde
Publikováno v:
Vaccines, Vol 12, Iss 6, p 642 (2024)
In patients with cancer, tumor- and treatment-induced immunosuppression are responsible for a four-fold increase in morbidity and mortality caused by influenza and invasive Streptococcus pneumoniae infections compared to the general population. The m
Externí odkaz:
https://doaj.org/article/4f0d7736358e4bd6b8c62608b2f1d0d4
Autor:
Maria Silvia Cona, Agostino Riva, Davide Dalu, Arianna Gabrieli, Cinzia Fasola, Giuseppe Lipari, Giacomo Pozza, Eliana Rulli, Francesca Galli, Lorenzo Ruggieri, Elsa Masedu, Gaia Parma, Davide Chizzoniti, Anna Gambaro, Sabrina Ferrario, Maria Antista, Matteo De Monte, Maciej S. Tarkowski, Nicla La Verde
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 12967-12974 (2023)
Abstract Introduction Cancer patients are frail individuals, thus the prevention of SARS‐CoV‐2 infection is essential. To date, vaccination is the most effective tool to prevent COVID‐19. In a previous study, we evaluated the immunogenicity of
Externí odkaz:
https://doaj.org/article/0ab5d2ba03cf4aae81056c5c142e801f
Autor:
Giulia Mentrasti, Luca Cantini, Patrizia Vici, Nicola D'Ostilio, Nicla La Verde, Rita Chiari, Vittorio Paolucci, Sonia Crocetti, Chiara De Filippis, Federica Pecci, Francesca Sofia Di Lisa, Donatella Traisci, Maria Silvia Cona, Linda Nicolardi, Laura Pizzuti, Simona Gildetti, Simone Oldani, Arianna Della Mora, Marco Luigi Bruno Rocchi, Rossana Berardi
Publikováno v:
Breast, Vol 65, Iss , Pp 164-171 (2022)
Purpose: Breast cancer (BC) patients’ (pts) management was affected by a global reorganization after Coronavirus disease 2019 (COVID-19). Our multicenter study aimed to assess the impact of COVID-19 on access to diagnosis, staging and treatment for
Externí odkaz:
https://doaj.org/article/5a1c9c5ec8c048d8a0f712de03031afa
Autor:
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 5, p 4974 (2023)
A significant proportion of patients treated for early breast cancer develop medium-term and late distant recurrence. The delayed manifestation of metastatic disease is defined as “dormancy”. This model describes the aspects of the clinical laten
Externí odkaz:
https://doaj.org/article/09f1969ca0d44aca8eaf15ad2c88719c
Autor:
Federica Miglietta, Maria Silvia Cona, Maria Vittoria Dieci, Valentina Guarneri, Nicla La Verde
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 1, Iss 6, Pp 452-472 (2020)
Although breast cancer is not traditionally considered an immunogenic type of tumor, the combination of immunotherapy and chemotherapy has recently emerged as a novel treatment option in triple-negative subtype in the advanced setting and other simil
Externí odkaz:
https://doaj.org/article/4ee0504bb2dd49738a1b472c282bcb25
Autor:
Claudio Vernieri, Michele Prisciandaro, Federico Nichetti, Riccardo Lobefaro, Giorgia Peverelli, Francesca Ligorio, Emma Zattarin, Maria Silvia Cona, Pierangela Sepe, Francesca Corti, Sara Manglaviti, Marta Brambilla, Barbara Re, Antonino Belfiore, Giancarlo Pruneri, Luigi Celio, Gabriella Mariani, Giulia Valeria Bianchi, Licia Rivoltini, Giuseppe Capri, Filippo de Braud
Publikováno v:
Cancers, Vol 12, Iss 3, p 617 (2020)
Background: Single-agent capecitabine (C) is a moderately effective chemotherapeutic compound in the treatment of patients with HER2-negative metastatic breast cancer (mBC). The capecitabine-vinorelbine (CV) combination is also used due to a good tol
Externí odkaz:
https://doaj.org/article/cccd6ffc20eb4fafa797d05db9ae3b15
Autor:
Maria Silvia Cona, Mara Lecchi, Sara Cresta, Silvia Damian, Michele Del Vecchio, Andrea Necchi, Marta Maria Poggi, Daniele Raggi, Giovanni Randon, Raffaele Ratta, Diego Signorelli, Claudio Vernieri, Filippo de Braud, Paolo Verderio, Massimo Di Nicola
Publikováno v:
Cancers, Vol 11, Iss 2, p 223 (2019)
Predictive biomarkers of response to immune-checkpoint inhibitors (ICIs) are an urgent clinical need. The aim of this study is to identify manageable parameters to use in clinical practice to select patients with higher probability of response to ICI
Externí odkaz:
https://doaj.org/article/ce6335c32b1a417681f71c1c7e6a01d1
Autor:
Sheila Piva, A. Gambaro, Francesca Galli, Nicla La Verde, Eliana Rulli, Virginio Filipazzi, D. Dalu, S. Ferrario, Maria Silvia Cona, N. Tosca, S. Rota
Publikováno v:
Supportive Care in Cancer
Introduction The study investigates the emotional discomfort of cancer patients and their caregivers, who need to access the oncology day hospital to receive treatment during the COVID-19 pandemic in Italy. Methods This is a single-institution, prosp
Autor:
Nicla La Verde, Agostino Riva, Maria Silvia Cona, Arianna Gabrieli, Monica Cattaneo, Cinzia Fasola, Giuseppe Lipari, Claudia De Stradis, Valentina Favorito, Benedetta Lombardi Stocchetti, Davide Chizzoniti, Alice Covizzi, Eliana Rulli, Francesca Galli, Lorenzo Ruggieri, Anna Gambaro, Sabrina Ferrario, Davide Dalu, Maciej S. Tarkowski
Publikováno v:
International journal of cancerREFERENCES. 152(4)
Previous studies on the immunogenicity of SARS-CoV-2 mRNA vaccines showed a reduced seroconversion in cancer patients. The aim of our study is to evaluate the immunogenicity of two doses of mRNA vaccines in solid cancer patients with or without a pre